Posted by Michael Wonder on 27 Jul 2021
J&J and Pfizer quietly resolve Remicade biosimilar lawsuit
27 July 2021 - In 2017, Pfizer filed a lawsuit against J&J alleging that the company undertook anticompetitive practices in a bid to protect Remicade.
As a result – Pfizer alleged – this restricted use of Pfizer's infliximab biosimilar Inflectra, which it originally launched in 2016.
